BPH (Benign Prostatic Hyperplasia): Clinical Trials

3 trials for BPH (Benign Prostatic Hyperplasia), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow BPH (Benign Prostatic Hyperplasia): new trials by email Literature Review of BPH (Benign Prostatic Hyperplasia) trials Research Report on BPH (Benign Prostatic Hyperplasia)

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Efficacy of Pyridostigmine Therapy After Transurethral Resection of Prostate in Cases with Underactive Urinary Bladder.
Pyridostigmine oral tablet, Placebo - Underactive Bladder, TURP(transurethral Resection of Prostate)
Phase 4CompletedMenoufia University662024-04-012025-03-26
The Efficacy and Safety of Qianweitai (Silodosin Capsule) Versus Tamsulosin in the Treatment of BPH
Silodosin, Tamsolusin - BPH (Benign Prostatic Hyperplasia)
Phase 4CompletedShanghai Huilun Pharmaceutical Co., Ltd.1102022-07-182025-08-21
KTP Green Light Prostatectomy Compared With Open Prostatectomy
KTP Green Light Prostatectomy, Green Light, Open prostatectomy - BPH (Benign Prostatic Hyperplasia)
Phase 4CompletedUniversity of Helsinki402011-09-012017-11-14

Narrower conditions

Prostatic Hyperplasia (3)  ·  Lower Urinary Tract Symptoms (1)  ·  Urinary Bladder, Underactive (1)

Broader conditions

Genital Diseases (3)  ·  Genital Diseases, Male (3)  ·  Male Urogenital Diseases (3)  ·  Prostatic Diseases (3)  ·  Urogenital Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Urological Manifestations (2)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Lower Urinary Tract Symptoms (1)  ·  Urinary Bladder Diseases (1)  ·  Urologic Diseases (1)

Interventions

Pyridostigmine Bromide (1)  ·  silodosin (1)

Sponsors

Menoufia University (1)  ·  Shanghai Huilun Pharmaceutical Co., Ltd. (1)  ·  University of Helsinki (1)

Countries

China (1)  ·  Egypt (1)  ·  Finland (1)

Top investigators

Shan Chen (1)